-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Hits New 12-Month High at $19.68
12 Jan 2024 15:19 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 1-Year High at $19.61
29 Dec 2023 17:03 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Short Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Declines By 81.1%
14 Dec 2023 18:42 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Sets New 1-Year High at $17.67
02 Dec 2023 13:17 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Sets New 52-Week High at $16.34
18 Nov 2023 15:22 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Posts Quarterly Earnings Results
27 Oct 2023 15:35 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 12-Month High at $16.09
14 Oct 2023 13:59 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, … ' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Comparing Virbac (OTC:VRBCF) & Chugai Pharmaceutical (OTCMKTS:CHGCY)
03 Sep 2023 13:22 GMT
… – Get Free Report) are both medical companies, but which is the … two stocks.
About Chugai Pharmaceutical
(Get Free Report)
Chugai Pharmaceutical Co., Ltd., together … other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and …
-
Jeil Pharmaceutical to exclusively sell osteoporosis drug Bonviva in Korea
08 Dec 2022 06:25 GMT
Jeil Pharmaceutical said on Thursday that the … supply of osteoporosis treatment Bonviva (ingredients: ibandronate sodium) and Bonviva Plus (ibandronate sodium … .K. pharmaceutical firm, and began marketing activities, the company said.
Bonviva effectively …
-
Chugai, Taisho & Roche ink pact to transfer and future marketing of osteoporosis agent Bonviva in Japan
25 Nov 2022 08:56 GMT
… ., Ltd. and Taisho Pharmaceutical Co., Ltd. announced … brand name: Bonviva tablet 100 mg] (collectively Bonviva), from Roche … Taisho should solely market Bonviva after transferring assets … information provision activities for Bonviva in Japan thereafter.
…